Proficiency testing results for catecholamines
| Variable | Year | Trial | Specimen no. | No. | Median | Minimum | Maximum |
|---|---|---|---|---|---|---|---|
| Catecholamines, plasma (pg/mL) | |||||||
| Dopamine | 2020 | 1st | CMCP-20-01 | 5 | 313.0 | 263.0 | 343.0 |
| CMCP-20-02 | 189.6 | 136.1 | 194.0 | ||||
| CMCP-20-03 | 82.0 | 81.8 | 104.7 | ||||
| 2nd | CMCP-20-04 | 5 | 87.9 | 23.5 | 104.9 | ||
| CMCP-20-05 | 234.2 | 221.8 | 333.1 | ||||
| CMCP-20-06 | 368.9 | 350.5 | 552.9 | ||||
| Epinephrine | 2020 | 1st | CMCP-20-01 | 5 | 1,211.0 | 1,100.0 | 1,515.3 |
| CMCP-20-02 | 644.2 | 578.0 | 796.3 | ||||
| CMCP-20-03 | 101.7 | 81.0 | 116.4 | ||||
| 2nd | CMCP-20-04 | 5 | 97.0 | 82.2 | 107.8 | ||
| CMCP-20-05 | 816.5 | 597.7 | 939.6 | ||||
| CMCP-20-06 | 1,575.4 | 1,115.5 | 1,738.0 | ||||
| Norepinephrine | 2020 | 1st | CMCP-20-01 | 5 | 1,319.0 | 1,264.8 | 1,450.9 |
| CMCP-20-02 | 784.6 | 679.0 | 882.9 | ||||
| CMCP-20-03 | 276.0 | 252.6 | 301.2 | ||||
| 2nd | CMCP-20-04 | 5 | 289.8 | 274.9 | 297.9 | ||
| CMCP-20-05 | 883.5 | 689.2 | 953.9 | ||||
| CMCP-20-06 | 1,463.6 | 1,101.6 | 1,640.1 | ||||
| Catecholamines, urine (ng/mL) | |||||||
| Dopamine | 2020 | 1st | CMU-20-01 | 6 | 421.5 | 333.7 | 438.3 |
| CMU-20-02 | 706.7 | 548.2 | 803.4 | ||||
| CMU-20-03 | 1,032.6 | 914.3 | 1,091.9 | ||||
| 2nd | CMU-20-04 | 6 | 564.2 | 508.7 | 679.9 | ||
| CMU-20-05 | 162.5 | 132.7 | 203.8 | ||||
| CMU-20-06 | 956.3 | 761.5 | 1,214.2 | ||||
| 2021 | 1st | CMCM-21-01 | 6 | 602.1 | 518.3 | 702.1 | |
| CMCM-21-02 | 352.5 | 308.2 | 425.5 | ||||
| CMCM-21-03 | 71.4 | 53.5 | 80.2 | ||||
| 2nd | CMCM-21-04 | 6 | 455.2 | 425.9 | 471.0 | ||
| CMCM-21-05 | 80.2 | 78.2 | 85.8 | ||||
| CMCM-21-06 | 251.9 | 235.5 | 263.7 | ||||
| Epinephrine | 2020 | 1st | CMU-20-01 | 6 | 23.8 | 18.7 | 25.9 |
| CMU-20-02 | 51.7 | 37.8 | 56.1 | ||||
| CMU-20-03 | 72.8 | 60.8 | 85.6 | ||||
| 2nd | CMU-20-04 | 6 | 48.0 | 40.4 | 52.1 | ||
| CMU-20-05 | 3.1 | 2.6 | 6.0 | ||||
| CMU-20-06 | 79.1 | 61.8 | 88.2 | ||||
| 2021 | 1st | CMCM-21-01 | 6 | 79.5 | 62.3 | 94.9 | |
| CMCM-21-02 | 36.6 | 27.0 | 40.6 | ||||
| CMCM-21-03 | 3.3 | 2.7 | 5.0 | ||||
| 2nd | CMCM-21-04 | 6 | 80.8 | 74.8 | 87.9 | ||
| CMCM-21-05 | 3.9 | 3.4 | 5.0 | ||||
| CMCM-21-06 | 45.1 | 40.5 | 48.6 | ||||
| Norepinephrine | 2020 | 1st | CMU-20-01 | 6 | 78.0 | 75.8 | 89.5 |
| CMU-20-02 | 200.9 | 164.4 | 210.6 | ||||
| CMU-20-03 | 285.1 | 238.1 | 324.1 | ||||
| 2nd | CMU-20-04 | 6 | 174.9 | 152.4 | 181.6 | ||
| CMU-20-05 | 26.2 | 20.4 | 48.9 | ||||
| CMU-20-06 | 289.3 | 222.5 | 311.7 | ||||
| 2021 | 1st | CMCM-21-01 | 6 | 219.9 | 197.2 | 263.1 | |
| CMCM-21-02 | 135.7 | 106.5 | 159.3 | ||||
| CMCM-21-03 | 16.9 | 15.6 | 18.0 | ||||
| 2nd | CMCM-21-04 | 6 | 214.9 | 194.5 | 225.0 | ||
| CMCM-21-05 | 18.8 | 14.5 | 21.8 | ||||
| CMCM-21-06 | 112.5 | 103.8 | 124.3 |